She's done it
Comments13
AFAIK @Joel Becker's introduction to EA was to find a good use for his earnings from his YouTube channel Messiseconds.
Excellent post. I love to see legible, reader-friendly summaries of high-level work on the forum. About time everyone updated their baseline knowledge on UVC.
Also, huge +1 to reaching out to Max expressing interest if anyone wants to work on this and feel that they bring something valuable to the table (even if something might not be available right away). I did this about six months ago and actually ended up contributing to a project. And what a great work experience it was overall!
Pan-Canadian action plan on antimicrobial resistance
https://www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html
This might be already on your radar but WHO just released its AMR research agenda. This might update the neglectedness of this issue.
I did end up in Mexico City. I plan to continue the job search from here while exploring independent contracting for some supplemental income and diverse project experience.
- If anyone is looking for expertise in biosecurity/global health to help with ongoing projects, please reach out and delegate to me! I am new here, so I haven't gathered any "EA karma" from well-written posts yet. I would love to change that!
LinkedIn
- I am open to ideas in up-skilling for the most impactful work I can do as a physician-scientist. Open to ideas for skills to master and funds to apply for the same.
- Also, EAs in the Americas, take a work-cation in CDMX! The weather is excellent, and the city is energetic and green. So far, a good group of EAs have been here after the fellowship ended. I would love to keep it up!
About "PPE procurement activities."
I was on the board of directors for the NY chapter of AAEM ( American Academy of Emergency Medicine), as a student representative. During the first wave of COVID in NYC, we were tasked by the leadership with a PPE procurement drive; this was later delegated to medical students around the city who were eager to help with the COVID effort and who had a lot of free time due to suspended classes. The drive was quite successful at a time when manual resources to track down suppliers, warehouse stocks, and sifting through the black market sources was difficult for hospital administrators.
Having seen this process up close, done by the volunteer time of medical students, the price tag of ~1M$ for this seems exceptionally ridiculous. The PPE procurement activities they proposed must have either been on an entirely different scale/direction or just over budgeted.
Thanks for your work.
The post mentions the work done in Goa, India, I would like to highlight the cost-effectiveness of the injectable rabies vaccine reported in the paper on the intervention done. "Elimination of human rabies in Goa". (I had read this paper once and thought the numbers were impressive. feel free to criticise it)
"The estimated mean cost per death averted and cost per DALY averted from 2013 to 2019 were 14,866 USD and 526 USD, respectively. During this period, the program was estimated to result in 2,249 DALYS averted and 80 deaths averted compared to no intervention. Over a 10-year projection (2013–2023), the intervention was estimated to prevent 121 human rabies deaths and 3427 DALYS at a mean cost of 567 USD per DALY averted."
Administering injectable vaccines does pose logistical issues; They report mean vaccination coverage in the 2016 campaign as 71.8% in all sighted dogs and 60.1% in roaming dogs. In 2017, intensive methods were applied state-wide, achieving an estimated coverage of 71.7% in all dogs sighted and 53.1% in the roaming population. Would improving operational efficiency in covering the free-roaming population of dogs with the traditional rabies vaccine be considered a good recommendation?